• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Surgar raises $12.3M for augmented reality solution for minimally invasive surgery

Surgar raises $12.3M for augmented reality solution for minimally invasive surgery

September 30, 2024 By Sean Whooley

Surgar Logo (1)Surgar announced that it closed a $12.3 million (€11 million) funding round to support its augmented reality software for surgery.

The France-based company develops augmented reality software that combines computer vision and AI. It merges the patient’s digital twin (obtained through MRI and CT scans) with a minimally invasive (laparoscopic) view in real-time. This enables surgeons to visualize internal organ structures (tumors, vessels, ducts).

Surgar said its technology helps make surgeries safer, faster and more efficient.

The company plans to use its funding to launch U-Surgar, a software dedicated to female patients suffering from fibroids and adenomyosis. Additionally, the company wants to finalize and commercialize its L-Surgar and K-Surgar offerings for liver and kidney cancers, respectively.

Sugar also has other AI-driven applications — including those for endometriosis — in development. Additionally, it has numerous collaborations and agreements with hospitals in France and abroad.

The round was led by Mutuelles Impact, managed by XAnge, along with Elaia Partners in partnership with MH Innov’, the corporate fund of Malakoff Humanis, Bpifrance through its Digital Venture fund, and several business angels (including Jacques Gardette, Thierry Joubert and Pierre-Jean Lamps. Existing investors UI Investissement, Crédit Agricole Capital Innovation, D-Novafund, G-Surge Consulting, Clermont Auvergne Innovation and the CHU of Clermont-Ferrand all participated. BNP Paribas, Crédit Agricole Centre France and Banque Populaire Auvergne Rhône-Alpes completed the financing. 

“Surgar is above all a human adventure and the result of long-standing collaboration,” CEO and founder Nicolas Bourdel said. “By addressing a critical need for surgeons, we are serving patients. We have just reached a decisive milestone with the CE marking of our first solution. With this funding, we are set to introduce the first-ever augmented reality solution for abdominal surgery. The challenges are significant, but the potential impact is even greater.”

Filed Under: Artificial Intelligence (AI), Business/Financial News, Digital Health, Funding Roundup, Health Technology, Machine Learning (ML), Software / IT, Surgical Tagged With: Surgar

More recent news

  • Retired Stryker leader Tim Scannell dies at 62
  • HighLife raises more than $90M to advance its TMVR system
  • UltraSight raises $24M in Series B2 to scale AI-guided cardiac ultrasound technology
  • Convatec launches new hydrophilic option for self-catheterization
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy